The Indian pharmaceutical giant, Wockhardt, is facing financial distress and this presents an golden chance for major players in the global pharmaceutical market. A recent fall in market capitalization has signaled potential vulnerability, making it a prime acquisition target for companies looking to grow their reach. With a rich history and exper